Tirzepatide × Prime Lab Peptides - Lab Test, November 2025
Test results
About this test
This independent assessment confirms Tirzepatide 30mg from Prime Lab Peptides at 99.737% purity. The analysis was conducted by Janoshik Labs on November 24, 2025, with testing ordered November 14, 2025, and sample received November 21, 2025.
Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for metabolic regulation, weight management, and glycemic control. A purity level of 99.737% indicates minimal contamination and high-grade synthesis.
The tested quantity of 31.42mg exceeds the stated label quantity of 30mg, demonstrating accurate or slightly elevated dosage. The full certificate of analysis is available for verification at www.janoshik.com/verify/ using the unique key 3LCB4R642K3W.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.